{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:34:59Z","timestamp":1780446899963,"version":"3.54.1"},"reference-count":9,"publisher":"Informa UK Limited","issue":"40","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sumitomo Pharma Switzerland GmbH"},{"DOI":"10.13039\/100014476","name":"Pfizer Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,12,22]]},"DOI":"10.1080\/14796694.2024.2418801","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T11:07:14Z","timestamp":1731928034000},"page":"3351-3354","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-0548","authenticated-orcid":false,"given":"Neal D","family":"Shore","sequence":"first","affiliation":[{"name":"Carolina Urologic Research Center","place":["Myrtle Beach, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Cookson","sequence":"additional","affiliation":[{"name":"The University of Oklahoma Health Sciences Center","place":["Oklahoma City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Efstathiou","sequence":"additional","affiliation":[{"name":"Houston Methodist Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S24106"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2012.25"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.03.273"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001969.12"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1328056"},{"key":"e_1_3_6_8_1","unstructured":"U.S. Food & Drug Administration. Prescribing information: ORGOVYX (relugolix) tablets for oral use. 2020. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/214621s000lbl.pdf (Accessed 16 May 2024)."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004325"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad099"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.12.019"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2024.2418801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:17:52Z","timestamp":1751455072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2024.2418801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":9,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2024,12,22]]}},"alternative-id":["10.1080\/14796694.2024.2418801"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2024.2418801","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}